Pfizer Inc. (PFE)
One click - and you get a custom homepage and a newsletter. Don't wait!
Stock Price Variations Over Last 10 Days
Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
Nov 19, 2017